A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
Clinical trial NCT01224106 · COMPLETED
Trial details
- NCT number
- NCT01224106
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-30
- Primary completion
- 2020-09-10
- Enrollment
- 799
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.